ABBOTT LABORATORIES

PAKISTAN (PVT) LIMITED

Presented By : Syed Faraz RizviMBA-II(Karachi University)

LayoutIntroduction

Vision & Mission Statement

Core Values

Products

SWOT Analysis

Achievements

Industry Info

Competitors

Market Share

Financial Data

Company InfoA Global Broad-Based Health Care Company.

Founded in USA about 120 years ago.

Operating In more than 130 Countries with over 70,000 Employees.

Business Operations

Pharmaceuticals

Nutritional

Diagnostics

Diabetes Care

Abbott PakistanAbbott Pakistan is a part of the Global Health Care Corporation of Abbott Laboratories, Chicago, USA.

Started operations in Pakistan in 1948.

Along with 1500 Employees with 2 Locations Abbott is discovering new

Medicines TechnologiesWays

To manage ‘Health’

Vision Statement

“To be a premier healthcare company in Pakistan”

Mission Statement

‘A Promise for Life’

Turning Science into Caring

Core ValuesPioneering Leading edge Science & Commercialization

Achieving World-Class Execution.

Caring Making a difference in people’s lives.

Enduring Commitment & purpose.

ProductsManufacturing more than 160 products

A broad range Including

Pharmaceutical Products

General Health Care Products

Nutritional Products

Diagnostics Products

Diabetes Care

Products

Pharmaceuticals Products

ProductsGeneral Health Care Products

Products

Nutritional Products

Products Diagnostics Products

Products Diabetes Care

Achievements

Abbott acquired Knoll BASF Pharma in 2000 for $6.9 billion.

On June 2005 Abbott achieved class ‘A’ accreditation against Oliver Wight ABCD checklist.

SWOT Analysis

Strengths

Good company Reputation

Strong Distribution Network

Strong Brand positioning

Deep roots in Pharma business

Professional Management Team

SWOT Analysis

Weaknesses

Comparatively High Prices

Relying on Imported Raw Material

Lacking of deep rural penetration

SWOT Analysis

Opportunities

A part of high potential Economy

High rate of population increase in

Pakistan

Increasing Healthcare awareness

SWOT Analysis

Threats

High Inflation rate

Foreign exchange rate

Political condition of Pakistan

Govt restriction on price

Industry Info

The Pakistan pharmaceutical industry meets around 70% of the country’s demand of finished medicine

With an export turnover of over US $ 100 million as of 2007.

Market Share divided into 59% Local 41% multinational

Market Share

GSK Highnoon Labs Getz Pharma Abbott Lab0

1

2

3

4

5

6

7

8 7.6

4.33.9

5.9

Market Share

Market Share

59% Local 41% multinationalSOME MAJOR PLAYERS IN PHARMA

INDUSTRY

Market Share

1st Qtr21%

2nd Qtr43%

3rd Qtr Aug,201036%

Sales 2010

YEAR PROFIT AFTER TAXATION(3rd Quarter)31 Aug-2010 Rs. 315,000,000(2nd Quarter & Half ended) May 31st, 2010.

Rs. 339,047,000

(1st Quarter) February 28, 2010. Rs. 184,519,000

Market ShareYEARS TOTAL SALES

(Rs in 000)PROFIT Rs 000(after taxation)

Net Profit to Sales %

2009 8,450,118 825,676 9.82008 7,123,412 343,980 4.82007 6,584,454 1,184,762 18.02006 5,914,181 1,000,008 16.9

2009

2008

2007

2006

0.00% 5.00% 10.00% 15.00% 20.00%

9.80%

4.80%

18.00%

16.90%

Net Profit to Sales

Net Profit to Sales %

To Employees

To Government

To Society

To Providers of Capital

To Providers of Finance

38.50%

22.41%

0.03%

44.35%

0.10%

2009 Spendings

2009

Future Aspect

•No Doubt upon Company’s ability to Continue as a going concern.

•Assets Rs. 4.9 Billion(2009)

•Cash in Hand only Rs. 770 Million(2009)